Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
NCT Number: NCT03588455
The intermediate coronary stenoses defined by a degree of stenosis from 40 to 70 % are frequent. The Flow Fraction Reserve (FFR), realized during coronarography, is an hemodynamic evaluation by the functional impact measuring the loss of load in upstream / approval of the stenosis inthe basal state and in situation of hyperemia led by adenosine. Further to the study FAME, the threshold of definition of the significant character of one Stenosis was fixed for a value of FFR = 0,80. However, the impact forecasts intermediate values badly known rest.
We hypothetized that coronary stenosis associated with borderline values of FFR 0.81-0.85 were associated with a higher rate of clinical events than those with a FFR >0.85
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, Île-de-France Region, 75014, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 years
cardiovascular mortality or acute coronary syndrom or revascularization or cardiovascular rehospitalisation
Fondation Hôpital Saint-Joseph
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07551518
Algorithm Validation for Fractional Flow Reserve Derived From Intravascular Ultrasound, Arterial Occlusive Diseases
Beijing, Select, China
View Trial DetailsNCT02100722
Cardiovascular Diseases, Coronary Disease
Palo Alto, California, United States
View Trial DetailsNCT05509296
Cardiovascular Diseases, Coronary Artery Stenosis
Beijing, China
View Trial DetailsNCT04475380
Acute Coronary Syndrome, Angina Pectoris
Enschede, Netherlands
View Trial Details